EichorEICHOR
Location: Goodyear Synced from ClinicalTrials.gov · August 08, 2026

Clinical studies recruiting near Goodyear

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide W
Phase 3 · Ironwood Physicians P.C. dba Ironwood Cancer and Research Ce · Pfizer · NCT07028853A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carbop
Phase 3 · City of Hope - Phoenix · Hoffmann-La Roche · NCT06793215Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Phase 3 · Clinical Study Site · Summit Therapeutics · NCT07228832A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in Fi
Phase 3 · City of Hope Cancer Center Phoenix · Amgen · NCT07005128A Phase 1 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants Wit
Phase 1 · City of Hope Phoenix Cancer Center · BeOne Medicines · NCT06427941A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
Phase 3 · Ironwood Cancer & Research Centers · Pfizer · NCT06629779A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-
Phase 2 · City of Hope - Phoenix ( Site 0202) · Merck Sharp & Dohme LLC · NCT06890884A Study of Momelotinib in Participants With Low-risk Myelodysplastic Syndrome
Phase 2 · GSK Investigational Site · GlaxoSmithKline · NCT06847867Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult
Phase 3 · Ironwood Cancer & Research Centers · Pfizer · NCT07222800Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic N
Phase 3 · Research Site · AstraZeneca · NCT07291037Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
NA · CTCA at Western Regional Medical Center · NRG Oncology · NCT05080673A Study to Investigate Ubamatamab With and Without REGN7075 in Adult Participants With Advanced/Metastatic Non-Small Cel
Phase 2 · Cancer Treatment Centers of America, Phoenix · Regeneron Pharmaceuticals · NCT07154290Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The Co
Phase 2 · CTCA at Western Regional Medical Center · National Cancer Institute (NCI) · NCT05564377Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagn
Phase 3 · CTCA at Western Regional Medical Center · SWOG Cancer Research Network · NCT06022939Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combina
Phase 2/Phase 3 · Local Institution - 007-556-A · Mirati Therapeutics Inc. · NCT04613596A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Phase 3 · CTCA at Western Regional Medical Center · National Cancer Institute (NCI) · NCT05675410A Multicenter Prospective Observational Cohort Study Evaluating the Impact of Cancer-Directed Treatment and Medication U
Phase N/A · CTCA at Western Regional Medical Center · City of Hope Medical Center · NCT07225738A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Le
Phase 3 · City of Hope - Phoenix · Hoffmann-La Roche · NCT06790693A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leuke
Phase 3 · Cancer Treatment Center of America Phoenix · Janssen Research & Development, LLC · NCT06852222Alpha Radiation Emitters (DaRT) With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic Cancer
NA · City of Hope · Alpha Tau Medical LTD. · NCT06698458Minimal Residual Disease Testing for the Early Detection of Cancer Recurrence in Resectable Stage II-IV Colorectal Cance
NA · CTCA at Western Regional Medical Center · City of Hope Medical Center · NCT07125729Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
Phase 3 · Western Reg MC-COH Phoenix · Novartis Pharmaceuticals · NCT05827081MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Ha
Phase 3 · Western Regional Medical Center, Inc. dba. City of Hope Phoe · Pfizer · NCT06152575Immunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and Selection of Second-line Treatmen
Phase 2 · CTCA at Western Regional Medical Center · City of Hope Medical Center · NCT07288034Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Phase 3 · CTCA at Western Regional Medical Center · ECOG-ACRIN Cancer Research Group · NCT03937635Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Phase 2/Phase 3 · CTCA at Western Regional Medical Center · SWOG Cancer Research Network · NCT03851445A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
NA · CTCA at Western Regional Medical Center · NRG Oncology · NCT04251052Neoadjuvant Botensilimab and Balstilimab for the Treatment of Advanced Resectable Colorectal Cancer NEST3
Phase 2 · CTCA at Western Regional Medical Center · City of Hope Medical Center · NCT07595874Study of Tarlatamab + ZL-1310 +/- Anti-programmed Death Ligand 1 (Anti-PD-L1) in Small Cell Lung Cancer (SCLC)
Phase 1 · City of Hope Cancer Center Phoenix · Amgen · NCT07531095Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After
Phase 3 · CTCA at Western Regional Medical Center · Alliance for Clinical Trials in Oncology · NCT05812807
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.